Glaxo chairman Philip Hampton stepping down

21st Jan 2019 07:14

(Sharecast News) - GlaxoSmithKline said chairman Sir Philip Hampton was stepping down and the board had started the process to find a successor."Following the announcement of our deal with Pfizer and the intended separation of the new consumer business, I believe this is the right moment to step down and allow a new chair to oversee this process through to its conclusion over the next few years and to lead the board into this next phase for GSK."